Akèy › Hypertension artérielle › Oklahoma
Etid klinik pou Hypertension artérielle nan Oklahoma
9 etid pou Hypertension artérielle ap chèche patisipan nan sit nan Oklahoma.
Vil nan Oklahoma
Tèks ofisyèl etid la (Anglè)
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
- CRO Call Center, Tulsa
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT07142356BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
- South Oklahoma Heart Research, Oklahoma City
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06059638A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- Oklahoma Heart Institute, Tulsa
Ap rekrite
Laj 18 a 85 · Tout sèks · Mizajou Oct 1, 2026 · NCT07214376EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Tekton Research Oklahoma City, Oklahoma City
- South Oklahoma Heart Research Group, Oklahoma City
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Central States Research, Tulsa
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07794579THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
- Ascension St. John Clinical Research Institute, Bartlesville
Ap rekrite
Laj 22 a 75 · Tout sèks · Mizajou Sep 24, 2026 · NCT06559891Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Edmond
- Clinical Trial Site, Moore
- Clinical Trial Site, Norman
- ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07181109An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
- Conrad Clinical Research, Edmond
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2026 · NCT07543120Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
- Vanda Investigative Site, Norman
- Vanda Investigative Site, Oklahoma City
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Feb 27, 2026 · NCT07090161Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.